Pancreas transplantation: the histologic morphology of graft loss and clinical correlations
- PMID: 11455259
- DOI: 10.1097/00007890-200106270-00014
Pancreas transplantation: the histologic morphology of graft loss and clinical correlations
Abstract
Background: Graft losses due to leaks, bleeding, thrombosis, infections, and early pancreatitis are grouped together under the category of technical failure. Among these complications, massive vascular thrombosis continues to be the most important cause of early graft loss due to technical failure. Pathological evaluation of most allografts lost early in the posttransplantation period shows vascular thrombosis with associated proportional parenchymal necrosis. The morphological findings in allografts that are considered to be lost due to technical failure has not been systematically addressed. In particular, the role of acute rejection in early graft loss has not been well studied.
Methods: Seventy-four consecutive pancreas graft pancreatectomies were studied histologically to evaluate for thrombosis (recent versus organized), type of vessel involved by thrombosis (arteries, veins, or both), acute rejection grade, chronic rejection grade, endotheliitis, transplant arteritis, coagulation necrosis, acute pancreatitis, presence of infectious organisms, transplant (obliterative) arteriopathy, neoplasia, relative proportions of alpha and beta islet cells, and immunoglobulin and complement deposition. The histological findings were correlated with donor and recipient data as well as clinical presentation.
Results: In 23 out of 39 grafts lost in the first 4 weeks posttransplantation, the only pathological changes found were vascular thrombosis and bland ischemic parenchymal necrosis. In these cases, no underlying vascular pathology or any other specific histological change was identified. Most of these grafts (78%) were lost in less than 48 hr and all in the first 2 weeks posttransplantation. Massive vascular thrombosis occurring in an otherwise histologically normal pancreas was the most common cause of graft loss in the first 4 weeks posttransplantation (59%). In most of the remaining cases (33%), although the clinical presentation suggested technical failure, there was clear histological evidence that the massive thrombosis resulted from vascular injury due to immune damage (acute and hyperacute rejection). Increased incidence of early graft thrombosis was seen in grafts from older donors and longer cold ischemia times. After the first month posttransplantation, graft pancreatectomies revealed a wider variety of pathological processes that included severe acute rejection, combined acute and chronic rejection, chronic rejection, and infections. Acute and chronic vascular thrombosis in large and small vessels was commonly seen at all times posttransplantation; chronic, organized thrombosis was strongly associated with chronic rejection.
Conclusions: (a) Early acute thrombosis occurring in a histologically normal pancreas defines a true technical failure. This study showed that acute rejection leading to massive thrombosis, which clinically simulates technical failure, results in a significant proportion of early graft losses. (b) Systematic histological evaluation of failed grafts is absolutely necessary for the accurate classification of the cause of graft loss. (c) There is morphological evidence that chronically ongoing thrombosis is an important, common, contributing factor for late graft loss.
Similar articles
-
Early allograft pancreatectomy-Technical failure or acute pancreatic rejection?Clin Transplant. 2019 Oct;33(10):e13702. doi: 10.1111/ctr.13702. Epub 2019 Sep 12. Clin Transplant. 2019. PMID: 31452273
-
Incidence and Histologic Features of Transplant Graft Pancreatitis: A Single Center Experience.Exp Clin Transplant. 2015 Oct;13(5):449-52. Exp Clin Transplant. 2015. PMID: 26450468
-
Epstein-Barr virus-related posttransplantation lymphoproliferative disorder involving pancreas allografts: histological differential diagnosis from acute allograft rejection.Hum Pathol. 1998 Jun;29(6):569-77. doi: 10.1016/s0046-8177(98)80005-1. Hum Pathol. 1998. PMID: 9635676
-
Complications after pancreas transplantation.Curr Opin Organ Transplant. 2010 Feb;15(1):112-8. doi: 10.1097/MOT.0b013e3283355349. Curr Opin Organ Transplant. 2010. PMID: 20009931 Review.
-
Allograft biopsies in management of pancreas transplant recipients.J Postgrad Med. 2002 Jan-Mar;48(1):56-63. J Postgrad Med. 2002. PMID: 12082334 Review.
Cited by
-
Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years.Am J Transplant. 2012 Dec;12(12):3363-76. doi: 10.1111/j.1600-6143.2012.04235.x. Epub 2012 Sep 4. Am J Transplant. 2012. PMID: 22946986 Free PMC article. Clinical Trial.
-
Role of Special Coagulation Studies for Preoperative Screening of Thrombotic Complications in Simultaneous Pancreas-Kidney Transplantation.Ochsner J. 2015 Fall;15(3):272-6. Ochsner J. 2015. PMID: 26413003 Free PMC article.
-
The role of donor hypertension and angiotensin II in the occurrence of early pancreas allograft thrombosis.Front Immunol. 2024 May 17;15:1359381. doi: 10.3389/fimmu.2024.1359381. eCollection 2024. Front Immunol. 2024. PMID: 38873595 Free PMC article.
-
Advances in pancreas transplantation.J R Soc Med. 2016 Apr;109(4):141-6. doi: 10.1177/0141076816636369. J R Soc Med. 2016. PMID: 27059905 Free PMC article. Review.
-
Hydrogen-rich saline protects against ischemia/reperfusion injury in grafts after pancreas transplantations by reducing oxidative stress in rats.Mediators Inflamm. 2015;2015:281985. doi: 10.1155/2015/281985. Epub 2015 Mar 22. Mediators Inflamm. 2015. PMID: 25873757 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical